Meeting report and review: Immunological assays and correlates of protection for next‐generation influenza vaccines

DOI Web Site Web Site 1 Citations
  • Florian Krammer
    Department of Microbiology Icahn School of Medicine at Mount Sinai New York City NY USA
  • Jerry P. Weir
    Division of Viral Products, Food and Drug Administration Bethesda MD USA
  • Othmar Engelhardt
    Division of Virology National Institute for Biological Standards and Control Potters Bar UK
  • Jacqueline M. Katz
    Formerly Influenza Branch Centers for Disease Control and Prevention (CDC) Atlanta GA USA
  • Rebecca Jane Cox
    Department of Clinical Science Influenza Centre University of Bergen Bergen Norway

Description

<jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>This report summarizes the discussions and conclusions from the “<jats:italic>Immunological Assays and Correlates of Protection for Next‐Generation Influenza Vaccines”</jats:italic> meeting which took place in Siena, Italy, from March 31, 2019, to April 2, 2019.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Furthermore, we review current correlates of protection against influenza virus infection and disease and their usefulness for the development of next generation broadly protective and universal influenza virus vaccines.</jats:p></jats:sec>

Journal

Citations (1)*help

See more

Report a problem

Back to top